Estados financieros detallados de Shattuck Labs, Inc. (STTK): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Shattuck Labs, Inc. registró ingresos de $1.0M en el último ejercicio fiscal, con un CAGR de 5 años del -36.8%.
Márgenes de los últimos 12 meses: margen bruto -7.5%, margen operativo -55.8%, margen neto -52.6%.
Al precio actual de $5.88, STTK presenta beneficios negativos (P/E no significativo) y un ROE del -43.57%. La capitalización bursátil es de $531M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $22.4M | $9.9M | $9.9M | $30.0M | $652000 | $1.7M | $5.7M | $1.0M |
| Coste de Ventas | $24.8M | $29.2M | $37.5M | $1.4M | $82.2M | $4.0M | $4.9M | $3.0M |
| Beneficio Bruto | -$2.4M | -$19.3M | -$27.5M | $28.6M | -$81.5M | -$2.4M | $827000 | -$2.0M |
| I+D | $24.8M | $29.2M | $37.5M | $56.6M | $82.9M | $74.3M | $67.2M | $35.3M |
| Generales y Administrativos | $3.8M | $5.7M | $9.4M | $18.7M | $19.7M | $19.3M | $19.1M | $17.2M |
| Gastos Operativos | $28.6M | $5.7M | $9.4M | $73.9M | $21.8M | $89.6M | $81.4M | $49.6M |
| Beneficio Operativo | -$6.1M | -$25.1M | -$36.9M | -$45.3M | -$103.3M | -$92.0M | -$80.6M | -$51.5M |
| EBITDA | -$4.5M | -$24.5M | -$36.3M | -$43.6M | -$98.9M | -$83.3M | -$71.6M | -$45.1M |
| Gastos por Intereses | $2.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$7.4M | -$24.0M | -$36.6M | -$45.0M | -$101.9M | -$87.3M | -$75.4M | -$48.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$7.4M | -$24.0M | -$36.6M | -$45.0M | -$101.9M | -$87.3M | -$75.4M | -$48.8M |
| BPA | $-0.49 | $-0.57 | $-0.88 | $-1.07 | $-2.41 | $-2.05 | $-1.49 | $-0.70 |
| BPA Diluido | $-0.49 | $-0.57 | $-0.88 | $-1.07 | $-2.41 | $-2.05 | $-1.49 | $-0.70 |
| Acciones en Circulación (Diluidas) | $15.0M | $41.7M | $41.8M | $42.0M | $42.4M | $42.6M | $50.8M | $69.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $1.0M | 0 | 0 | 0 |
| Beneficio Bruto | -$6.6M | 0 | -$891000 | 0 |
| Beneficio Operativo | -$10.7M | -$13.4M | -$15.5M | -$16.2M |
| EBITDA | -$9.1M | -$11.7M | -$13.9M | -$13.8M |
| Beneficio Neto | -$10.1M | -$12.6M | -$14.8M | -$15.2M |
| BPA | $-0.14 | $-0.12 | $-0.13 | $-0.12 |
| BPA Diluido | $-0.14 | $-0.12 | $-0.13 | $-0.12 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $31.6M | $7.0M | $157.9M | $92.3M | $47.4M | $125.6M | $57.4M | $54.2M |
| Inversiones a Corto | $28.7M | $32.1M | $177.6M | $176.5M | $113.9M | $5.0M | $15.6M | $23.9M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $65.6M | $42.4M | $345.6M | $288.3M | $184.6M | $143.2M | $79.2M | $82.5M |
| Inmovilizado Material | $2.5M | $2.4M | $3.0M | $9.9M | $17.7M | $13.8M | $9.8M | $6.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $68.2M | $45.0M | $349.0M | $298.6M | $205.3M | $159.6M | $91.0M | $91.0M |
| Cuentas por Pagar | $2.0M | $3.1M | $1.8M | $10.0M | $7.2M | $1.6M | $2.4M | $2.1M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $20.9M | $20.0M | $16.8M | $24.6M | $25.0M | $11.5M | $8.9M | $7.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.6M |
| Pasivos Totales | $79.2M | $79.5M | $39.1M | $26.8M | $29.2M | $14.9M | $11.4M | $8.6M |
| Reservas | -$11.5M | -$35.5M | -$72.1M | -$117.1M | -$219.0M | -$306.3M | -$381.7M | -$430.5M |
| Patrimonio Neto | -$11.1M | -$34.5M | $309.9M | $271.8M | $176.2M | $144.7M | $79.6M | $82.4M |
| Deuda Total | 0 | 0 | 0 | 0 | $4.9M | $4.2M | $3.4M | $2.4M |
| Deuda Neta | -$60.4M | -$39.1M | -$335.4M | -$268.8M | -$156.4M | -$126.4M | -$69.6M | -$75.6M |
| Capital Circulante | $44.8M | $22.5M | $328.8M | $263.7M | $159.6M | $131.8M | $70.3M | $75.4M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $42.5M | $54.2M | $90.4M | $63.3M |
| Activos Totales | $100.3M | $91.0M | $102.1M | $220.7M |
| Pasivos Totales | $7.1M | $8.6M | $6.3M | $9.5M |
| Patrimonio Neto | $93.2M | $82.4M | $95.8M | $211.1M |
| Deuda Total | $2.6M | $2.4M | $2.9M | $2.7M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$7.4M | -$24.0M | -$36.6M | -$45.0M | -$101.9M | -$87.3M | -$75.4M | -$48.8M |
| Amortizaciones | $255000 | $537000 | $618000 | $1.4M | $3.1M | $4.0M | $3.8M | $3.7M |
| Compensación en Acciones | $425000 | $461000 | $1.3M | $5.5M | $6.5M | $6.9M | $9.5M | $7.0M |
| Cambio en Capital Circulante | -$2.5M | $2.2M | $970000 | -$23.5M | -$4.5M | -$4.1M | $3.0M | -$785000 |
| Flujo de Caja Operativo | -$6.9M | -$21.0M | -$33.7M | -$57.1M | -$94.5M | -$81.2M | -$60.5M | -$39.9M |
| Inversiones (CapEx) | -$1.2M | -$470000 | -$727000 | -$7.9M | -$11.6M | -$407000 | -$59000 | -$71000 |
| Adquisiciones | 0 | 0 | $145.6M | $2.5M | $104000 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$8.1M | -$21.4M | -$34.4M | -$65.0M | -$106.1M | -$81.6M | -$60.6M | -$40.0M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$8.9M | -$8.5M | -$13.4M | -$10.2M |
| Inversiones (CapEx) | -$71000 | 0 | 0 | -$141000 |
| Flujo de Caja Libre | -$9.0M | -$8.5M | -$13.4M | -$10.3M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.8M | $1.6M | $2.4M | $2.7M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -55.9% | +0.5% | +202.2% | -97.8% | +154.1% | +245.3% | -82.5% |
| Crecimiento Beneficio Neto (anual) | | -224.6% | -52.6% | -22.9% | -126.7% | +14.4% | +13.6% | +35.3% |
| Crecimiento BPA (anual) | | -16.3% | -54.4% | -21.6% | -125.2% | +14.9% | +27.3% | +53.0% |
| Cambio en Acciones (anual) | | +177.5% | +0.1% | +0.6% | +0.8% | +0.5% | +19.2% | +37.1% |
| Crecimiento FCF (anual) | | -165.4% | -60.3% | -89.2% | -63.1% | +23.1% | +25.8% | +34.0% |
| Margen Bruto | -10.5% | -195.5% | -277.3% | 95.4% | -12507.2% | -143.9% | 14.5% | -195.1% |
| Margen Operativo | -27.4% | -253.5% | -371.8% | -150.8% | -15848.0% | -5549.6% | -1408.3% | -5150.8% |
| Margen EBITDA | -20.1% | -248.1% | -365.5% | -145.2% | -15164.4% | -5024.5% | -1251.2% | -4512.1% |
| Margen Neto | -32.9% | -242.6% | -368.5% | -149.8% | -15635.7% | -5268.4% | -1318.1% | -4880.9% |
| Margen FCF | -36.0% | -216.9% | -346.1% | -216.7% | -16274.8% | -4926.7% | -1058.8% | -3995.3% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.54 | $-0.51 | $-0.82 | $-1.55 | $-2.50 | $-1.92 | $-1.19 | $-0.57 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $15.0M | $41.7M | $41.8M | $42.0M | $42.4M | $42.6M | $50.8M | $69.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -43.57% |
| Rentabilidad sobre capital invertido | -26.09% |
| Rentabilidad sobre activos | -23.82% |
| Margen bruto | -750.90% |
| Margen operativo | -5578.70% |
| Margen neto | -5256.80% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 27.59 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -39.49 | -33.95 | -59.56 | -7.95 | -0.95 | -3.48 | -0.81 | -5.21 |
| P/VC | -26.27 | -23.38 | 7.06 | 1.32 | 0.55 | 2.10 | 0.77 | 3.08 |
| P/V | 12.97 | 81.70 | 220.36 | 11.92 | 149.50 | 183.31 | 10.74 | 253.99 |
| Margen Bruto | -10.5% | -195.5% | -277.3% | 95.4% | -12507.2% | -143.9% | 14.5% | -195.1% |
| Margen Operativo | -27.4% | -253.5% | -371.8% | -150.8% | -15848.0% | -5549.6% | -1408.3% | -5150.8% |
| Margen Neto | -32.9% | -242.6% | -368.5% | -149.8% | -15635.7% | -5268.4% | -1318.1% | -4880.9% |